SCHEMBL14599692

SCHEMBL14599692

CCOC(=O)COc1ccc(-c2c3nc(c(C#Cc4cccc(O)c4)c4ccc([nH]4)c(C#Cc4cccc(O)c4)c4nc(c(C#Cc5cccc(O)c5)c5ccc2s5)C=C4)C=C3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.38
▸ F9 P00740 1/20 0.37
▸ F10 P00742 1/20 0.37
▸ PDE3B Q13370 1/20 0.36
▸ PDE3A Q14432 1/20 0.36
▸ P2RY12 Q9H244 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.35
▸ HPGD P15428 4/20 0.35
▸ HSD17B10 Q99714 4/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ADORA2A P29274 3/20 0.35
▸ ADORA2B P29275 3/20 0.35
▸ PRMT5 O14744 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14599693 0.88 F9 (0.36) F9F10PDE3BPDE3AP2RY12
SCHEMBL14599694 0.88 F9 (0.37) F9F10PDE3BPDE3AP2RY12
SCHEMBL14629716 0.86 F9 (0.43) F9F10PDE3BPDE3AP2RY12
SCHEMBL14599696 0.78 FFAR1 (0.35) FFAR1ADORA2AADORA2BPTPN1
SCHEMBL14599691 0.77 PDE3B (0.41) F9F10PDE3BPDE3AP2RY12
SCHEMBL8907605 0.75 ABCG2 (0.52) PDE3BPDE3AP2RY12KDM4EHPGD
SCHEMBL14599697 0.74 — —
SCHEMBL1551074 0.72 FFAR1 (0.69) FFAR1KDM4EHPGDHSD17B10ALDH1A1
SCHEMBL14599689 0.69 ADORA2B (0.39) F9F10PDE3BPDE3AP2RY12
SCHEMBL14599677 0.66 L3MBTL1 (0.38) KDM4EHPGDALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015742-A1 Porphyrin derivatives YAHIOGLU GOKHAN 2007-01-18 — — US disclosed
US-20070015742-A1 Porphyrin derivatives YAHIOGLU GOKHAN 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015742-A1 Porphyrin derivatives SCO2, CBR3, CBR1 FFAR1 2302/4885F9 1407/4885F10 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback